Suchergebnisse - "Thuluvath, Paul J"

PubPharm (19)

1

A phase II, randomized, open-label, 52-week study of seladelpar in patients with primary biliary cholangitis

enthalten in: Journal of hepatology | 2022

von Bowlus, C. | Galambos, M. | Aspinall, R. | +21

CommentIn: J Hepatol. 2022 Nov;77(5):1451. - PMID 35594993

2

Aldafermin in patients with non-alcoholic steatohepatitis (ALPINE 2/3) : a randomised, double-blind, placebo-controlled, phase 2b trial

enthalten in: The lancet. Gastroenterology & hepatology | 2022

von Harrison, S. | Abdelmalek, M. | Neff, G. | +27

CommentIn: Lancet Gastroenterol Hepatol. 2022 Jul;7(7):586-587. - PMID 35325621

3

Emricasan to prevent new decompensation in patients with NASH-related decompensated cirrhosis

enthalten in: Journal of hepatology | 2021

von Frenette, C. | Kayali, Z. | Mena, E. | +77

4

Randomized placebo-controlled trial of emricasan for non-alcoholic steatohepatitis-related cirrhosis with severe portal hypertension

enthalten in: Journal of hepatology | 2020

von Garcia-Tsao, G. | Bosch, J. | Kayali, Z. | +73

CommentIn: J Hepatol. 2021 May;74(5):1269-1270. - PMID 33340573

5

High SVR12 with 8-week and 12-week glecaprevir/pibrentasvir therapy : An integrated analysis of HCV genotype 1-6 patients without cirrhosis

enthalten in: Journal of hepatology | 2018

von Puoti, M. | Foster, G. | Wang, S. | +16

6

Daclatasvir + asunaprevir + beclabuvir ± ribavirin for chronic HCV genotype 1-infected treatment-naive patients

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2016

von Everson, G. | Sims, K. | Thuluvath, P. | +17

CommentIn: Liver Int. 2016 Feb;36(2):181-4. - PMID 26781595

7

Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection

enthalten in: The New England journal of medicine | 2015

von Feld, J. | Jacobson, I. | Hézode, C. | +103

CommentIn: N Engl J Med. 2016 Apr 28;374(17):1688-9

8

Sofosbuvir With Velpatasvir in Treatment-Naive Noncirrhotic Patients With Genotype 1 to 6 Hepatitis C Virus Infection : A Randomized Trial

enthalten in: Annals of internal medicine | 2015

von Everson, G. | Towner, W. | Davis, M. | +15

9

Daclatasvir plus peginterferon alfa and ribavirin for treatment-naive chronic hepatitis C genotype 1 or 4 infection : a randomised study

enthalten in: Gut | 2015

von Hézode, C. | Hirschfield, G. | Ghesquiere, W. | +31

10

A randomized trial of daclatasvir in combination with asunaprevir and beclabuvir in patients with chronic hepatitis C virus genotype 4 infection

enthalten in: Journal of hepatology | 2015

von Hassanein, T. | Sims, K. | Bennett, M. | +16

CommentIn: J Hepatol. 2015 May;62(5):996-9. - PMID 25747660